Cargando…

Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development

CNS inflammation is a major driver of MS pathology. Differential immune responses, including the adaptive and the innate immune system, are observed at various stages of MS and drive disease development and progression. Next to these immune-mediated mechanisms, other mediators contribute to MS patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pegoretti, Valentina, Swanson, Kathryn A., Bethea, John R., Probert, Lesley, Eisel, Ulrich L. M., Fischer, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240663/ https://www.ncbi.nlm.nih.gov/pubmed/32454942 http://dx.doi.org/10.1155/2020/7191080

Ejemplares similares

Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment
por: Pegoretti, Valentina, et al.
Publicado: (2018)

Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis
por: Padureanu, Rodica, et al.
Publicado: (2019)

Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis
por: Haider, Lukas
Publicado: (2015)

Hydroxycitric acid ameliorates inflammation and oxidative stress in mouse models of multiple sclerosis
por: Goudarzvand, Mahdi, et al.
Publicado: (2016)

Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results
por: Vezzoli, Alessandra, et al.
Publicado: (2023)

Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models
por: Schuh, Cornelia, et al.
Publicado: (2014)

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
por: Pegoretti, Valentina, et al.
Publicado: (2023)

Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
por: Williams, Sarah K., et al.
Publicado: (2018)

Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
por: Fischer, Roman, et al.
Publicado: (2015)

A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann’s syndrome
por: Gnanapavan, Sharmilee, et al.
Publicado: (2014)

Inflammation in multiple sclerosis
por: Haase, Stefanie, et al.
Publicado: (2021)

Oxidative Stress and Vitamin D as Predictors in Multiple Sclerosis
por: PĂDUREANU, RODICA, et al.
Publicado: (2020)

Oxidative stress in multiple sclerosis—Emerging imaging techniques
por: Hollen, Christopher, et al.
Publicado: (2023)

Oxidative stress-related risk of the multiple sclerosis development
por: Vasić, Marija, et al.
Publicado: (2023)

Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
por: Uher, Tomas, et al.
Publicado: (2023)

Oxidative damage in multiple sclerosis lesions
por: Haider, Lukas, et al.
Publicado: (2011)

Neurobiological Consequences of Oxidative Stress
Publicado: (2014)

Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
por: Androutsou, Maria-Eleni, et al.
Publicado: (2020)

Oxidative and nitrative stress as a pathogenic factor in multiple sclerosis
por: Lukáč, Štefan, et al.
Publicado: (2013)

Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis
por: Aydin, Ozgur, et al.
Publicado: (2014)

Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach
por: Ortiz, Genaro G., et al.
Publicado: (2013)

Oxidative stress in multiple sclerosis: Central and peripheral mode of action
por: Ohl, Kim, et al.
Publicado: (2016)

Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis
por: Doridot, Ludivine, et al.
Publicado: (2019)

Oxidative Stress in Infection and Consequent Disease
por: Ivanov, Alexander V., et al.
Publicado: (2017)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Resolution of inflammation during multiple sclerosis
por: Ruiz, F., et al.
Publicado: (2019)

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2019)

Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10
por: Moccia, Marcello, et al.
Publicado: (2019)

CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
por: Mir, Fozia, et al.
Publicado: (2014)

Role of Peripheral Immune Cells for Development and Recovery of Chronic Pain
por: Bethea, John R., et al.
Publicado: (2021)

Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown
por: Moss, Heather E
Publicado: (2017)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis
por: Gatta, Valentina, et al.
Publicado: (2020)

Oxidative Stress in Kidney Diseases: The Cause or the Consequence?
por: Krata, Natalia, et al.
Publicado: (2017)

Oxidative stress: culprit or consequence in Alzheimer’s amyloidopathy
por: Sharma, Chanchal, et al.
Publicado: (2023)

NLR-Dependent Regulation of Inflammation in Multiple Sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2018)

T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
por: Kunkl, Martina, et al.
Publicado: (2020)

New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
por: Adamczyk, Bożena, et al.
Publicado: (2016)

Oxidative Stress Marker Aberrations in Multiple Sclerosis: A Meta-Analysis Study
por: Zhang, Shu-Yao, et al.
Publicado: (2020)

Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug Repositioning
por: Olla, Stefania, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n9vmr0pcub711rurm1qr6g150f